Insight into the Mechanisms of Cocrystallization of Pharmaceuticals in Supercritical Solvents
暂无分享,去创建一个
Henrique A. Matos | Sitaram Velaga | Miguel A. Rodrigues | Luis Padrela | H. Matos | S. Velaga | M. Rodrigues | E. Azevedo | L. Padrela | Edmundo Gomes de Azevedo | João M. Tiago | João Tiago
[1] R. Gobetto,et al. Didanosine polymorphism in a supercritical antisolvent process. , 2010, Journal of pharmaceutical sciences.
[2] Michael J. Zaworotko,et al. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2004 .
[3] Henrique A. Matos,et al. Single-Step Co-Crystallization and Lipid Dispersion by Supercritical Enhanced Atomization , 2013 .
[4] Amjad Alhalaweh,et al. Bioavailability of indomethacin‐saccharin cocrystals , 2010, The Journal of pharmacy and pharmacology.
[5] J. Wuest,et al. Molecular solids: Co-crystals give light a tune-up. , 2012, Nature chemistry.
[6] William Jones,et al. Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding , 2009 .
[7] I. Pentchev,et al. Impregnation isotherms of hydroxybenzoic acid on PMMA in supercritical carbon dioxide , 2007 .
[8] S. Velaga,et al. Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization , 2008, Pharmaceutical Research.
[9] Luis Padrela,et al. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture , 2012, Drug development and industrial pharmacy.
[10] Raj Suryanarayanan,et al. A rapid thermal method for cocrystal screening , 2008 .
[11] Luis Padrela,et al. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] David R. Weyna,et al. Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution , 2009 .
[13] J. Wouters,et al. Pharmaceutical Salts and Co-crystals , 2011 .
[14] H. Uchida,et al. Growth Phenomena of Single Crystals of Naphthalene in Supercritical Carbon Dioxide , 2004 .
[15] Aeri Park,et al. Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.
[16] F. Giordano,et al. Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] S. Laugier,et al. Effect of CO2-antisolvent techniques on size distribution and crystal lattice of theophylline , 2011 .
[18] Ning Shan,et al. The role of cocrystals in pharmaceutical science. , 2008, Drug discovery today.
[19] M. Mazzotti,et al. Gas Antisolvent Recrystallization of Paracetamol from Acetone Using Compressed Carbon Dioxide as Antisolvent , 2004 .
[20] M. J. Cocero,et al. Production of Polymorphs of Ibuprofen Sodium by Supercritical Antisolvent (SAS) Precipitation , 2009 .
[21] Dan Boström,et al. Pharmaceutical Cocrystal and Salts of Norfloxacin , 2006 .
[22] H. Matos,et al. Theophylline polymorphs by atomization of supercritical antisolvent induced suspensions , 2011 .
[23] A. Newman,et al. Pharmaceutical Cocrystals and Their Physicochemical Properties , 2009, Crystal growth & design.
[24] W. Jiskoot,et al. Selective Production of Polymorphs and Pseudomorphs Using Supercritical Fluid Crystallization from Aqueous Solutions , 2007 .
[25] G. Brunner,et al. Solubilities of the xanthines caffeine, theophylline and theobromine in supercritical carbon dioxide , 1994 .
[26] Henrique A. Matos,et al. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process , 2010 .